• Home
  • About
  • Press
  • Services
  • Legal
  • Payment
  • Contact
  • Facebook
  • Twitter
The Wall Street Analyzer

  • Featured Interviews
  • CEO Interviews
  • News Feed
  • Spotlight
  • Sectors
    • Biotech
    • Cannabis
    • Consumer
    • Energy
    • Healthcare
    • Market News
    • Technology
Latest News
  • [ February 2, 2023 ] XORTX Announces Submission of Orphan Drug Designation Request for XRx-008 Program to Treat Autosomal Dominant Kidney Disease News Feed
  • [ January 31, 2023 ] Zerify Starts The Year Off Strong News Feed
  • [ January 26, 2023 ] SCOTTIE RESOURCES INTERCEPTS 34.5 G/T GOLD OVER 4.7 METRES ON BLUEBERRY CONTACT ZONE News Feed
  • [ January 24, 2023 ] Zomedica to Participate in the Lytham Partners Investor Select Conference News Feed
  • [ January 23, 2023 ] XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial News Feed
  • [ January 18, 2023 ] Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies News Feed
  • [ January 17, 2023 ] SCOTTIE RESOURCES ANNOUNCES BOARD APPOINTMENT OF ELLIE OWENS News Feed
Home2016June

Month: June 2016

No Picture
CEO Interviews

NanoDimension Ltd (NASDAQ: NNDM) (TASE: NNDM) CEO: Amit Dror

June 24, 2016 The Wall Street Analyzer Comments Off on NanoDimension Ltd (NASDAQ: NNDM) (TASE: NNDM) CEO: Amit Dror

NanoDimension Ltd (NASDAQ: NNDM) (TASE: NNDM) CEO: Amit Dror   THIS INTERVIEW HAS EXPIRED

No Picture
CEO Interviews

Isoray, Inc (NYSE:ISR) CEO Interview

June 23, 2016 The Wall Street Analyzer Comments Off on Isoray, Inc (NYSE:ISR) CEO Interview

Interview with CEO Tom Lavoy […]

No Picture
CEO Interviews

TapImmune, Inc. (OTCQB: TPIV) CEO Interview Series

June 22, 2016 The Wall Street Analyzer Comments Off on TapImmune, Inc. (OTCQB: TPIV) CEO Interview Series

Interview with Glynn Wlson, CEO […]

No Picture
CEO Interviews

Mast Therapeutics (NYSEMKT: MSTX) CEO Interview

June 22, 2016 The Wall Street Analyzer Comments Off on Mast Therapeutics (NYSEMKT: MSTX) CEO Interview

Interview with Brian Culley, CEO […]

No Picture
CEO Interviews

ClearOne, Inc. (NASDAQ: CLRO) CEO Interview Series

June 14, 2016 The Wall Street Analyzer Comments Off on ClearOne, Inc. (NASDAQ: CLRO) CEO Interview Series

Interview with Zee Hakimoglu, CEO […]

No Picture
CEO Interviews

EndoChoice Holdings Inc (NYSE:GI) CEO Interview

June 7, 2016 The Wall Street Analyzer Comments Off on EndoChoice Holdings Inc (NYSE:GI) CEO Interview

Interview with CEO Mark Gilreath […]

No Picture
CEO Interviews

Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) CEO Interview

June 2, 2016 The Wall Street Analyzer Comments Off on Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) CEO Interview

Interview with CEO Nadav Kidron […]

No Picture
CEO Interviews

Remark Media Inc (NASDAQ:MARK) CEO Interview

June 2, 2016 The Wall Street Analyzer Comments Off on Remark Media Inc (NASDAQ:MARK) CEO Interview

Interview with CEO Kai-Shing Tao […]

No Picture
CEO Interviews

Biostage Inc (NASDAQ:BSTG) CEO Interview

June 1, 2016 The Wall Street Analyzer Comments Off on Biostage Inc (NASDAQ:BSTG) CEO Interview

Interview with COE Jim McGorry […]

No Picture
CEO Interviews

CryoPort Inc (NASDAQ:CYRX) CEO Interview

June 1, 2016 The Wall Street Analyzer Comments Off on CryoPort Inc (NASDAQ:CYRX) CEO Interview

Interview with with CEO Jerrell Shelton […]

Featured Companies

CEO Interviews

Zomedica Corp. (NYSE American: ZOM)

November 29, 2022 0

Interview update with Larry Heaton, CEO and President […]

CEO Interviews

Acutus Medical (NASDAQ: AFIB)

November 19, 2022 0

Interview with David Roman, CEO […]

Featured Interviews

Zerify (OTCQB: ZRFY)

November 18, 2022 0

Interview with Mark Kay, CEO and Chairman […]

Featured Interviews

Xortx Therapeutics (CSE: XRX) (NASDAQ: XRTF)

October 25, 2022 0

Interview update with Dr. Allen Davidoff, CEO
[…]

CEO Interviews

Pro-Dex, Inc (NASDAQ: PDEX) CEO Interview Update

October 24, 2022 0

Interview with Rick Van Kirk, CEO […]

News Wire

  • XORTX Announces Submission of Orphan Drug Designation Request for XRx-008 Program to Treat Autosomal Dominant Kidney Disease
    February 2, 2023 0
  • Zerify Starts The Year Off Strong
    January 31, 2023 0
  • SCOTTIE RESOURCES INTERCEPTS 34.5 G/T GOLD OVER 4.7 METRES ON BLUEBERRY CONTACT ZONE
    January 26, 2023 0
  • Zomedica to Participate in the Lytham Partners Investor Select Conference
    January 24, 2023 0
  • XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial
    January 23, 2023 0
  • Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies
    January 18, 2023 0
  • SCOTTIE RESOURCES ANNOUNCES BOARD APPOINTMENT OF ELLIE OWENS
    January 17, 2023 0




Follow on Facebook

About Us

The Wall Street Analyzer's staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum.
Quick links
  • Home
  • About
  • Press
  • Services
  • Legal
  • Payment
  • Contact
Stay connected
  • Facebook
  • Twitter
Recent Case Study
Biotech

Co-Diagnostics (NASDAQ: CODX) is Well-positioned with 3 Key Verticals

August 12, 2019 Comments Off on Co-Diagnostics (NASDAQ: CODX) is Well-positioned with 3 Key Verticals

About Co-Diagnostics, Inc: Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company’s technology is utilized for tests that are designed using the detection […]

Testimonials
Testimonials

Client Testimonials:

June 1, 2020 Comments Off on Client Testimonials:

“What we like most about the wallstreetanalyzer.com was their service consistently brought Marifil Mines Ltd new viewers to our company.  The interviews are high quality, to the point, friendly and enlightening.  We have been using his […]

Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com